Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation.
about
Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panelLocal and global cerebral blood flow and glucose utilization in the alpha-galactosidase A knockout mouse model of Fabry diseaseAvascular necrosis of the femoral head in a patient with Fabry's disease: identification of ceramide trihexoside in the bone by delayed-extraction matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders.Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease.Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy.Impaired small fiber conduction in patients with Fabry disease: a neurophysiological case-control studyFabry disease - underestimated in the differential diagnosis of multiple sclerosis?Clinical prodromes of neurodegeneration in Anderson-Fabry disease.The Fabry disease-associated lipid Lyso-Gb3 enhances voltage-gated calcium currents in sensory neurons and causes pain.Eight-Year Follow-Up of Neuropsychiatric Symptoms and Brain Structural Changes in Fabry DiseaseSkin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease.Voxel based analyses of diffusion tensor imaging in Fabry disease.Carpal tunnel syndrome in fabry disease.Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies.Increased expression of Trpv1 in peripheral terminals mediates thermal nociception in Fabry disease mouse model.Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease.Electroneuromyographic Features in Fabry Disease: A Retrospective Review.Fabry disease: a rare cause of neuropathic pain.Changes in Ionic Conductance Signature of Nociceptive Neurons Underlying Fabry Disease Phenotype.Bone and joint involvement in Fabry disease.The lysosomal enzyme alpha-Galactosidase A is deficient in Parkinson's disease brain in association with the pathologic accumulation of alpha-synuclein.Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density.Redefining the Pulvinar Sign in Fabry Disease.Neuropsychiatric symptoms and brain structural alterations in Fabry disease.Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis.White matter lesions in Fabry disease before and after enzyme replacement therapy: a 2-year follow-up.Hippocampal atrophy as a surrogate of neuronal involvement in Fabry disease.Fabry's disease and psychosis: causality or coincidence?Neuropathic pain in a Fabry disease rat model.Reduced Intracranial Volume in Fabry Disease: Evidence of Abnormal Neurodevelopment?
P2860
Q21261394-80F83AA4-2E6A-49DB-9DD2-7EE6FCCBD473Q28506514-3F276107-326D-477C-86F7-4E3C581DBCA7Q30837542-0BEC1E35-D862-499D-B976-C39198C6320FQ31028468-277EDC90-EAAA-4128-B112-876F2FBBEAB8Q33179389-E477C4F0-DD56-423D-AE56-F65D625EAF92Q33866320-D3CC5D3A-7BF5-412A-ACE5-445C003F235DQ34739186-974DE3E8-A082-4014-9D1D-F85409FA8516Q34981327-047D5CB8-B737-4E45-87B3-04C57843F61FQ35327083-CA7CD114-CE52-44E6-ABF5-29A9D04B4A5FQ35542977-E122C007-B53E-4F1E-B3F1-2F18FF3F4013Q35764867-93509874-0910-4CA3-A2D8-A873B53B3646Q36193984-E4923CB5-98F0-4B2A-9CEC-B6EA07DF7962Q36227485-ED815784-FAB2-4C42-B084-195346BD0ABEQ36433270-26D2092F-A836-48F8-829B-2EBA3F5DED72Q37036740-1B045BC6-2C8C-4685-B9FA-8BAFA5D3F5A1Q37229008-84D016C3-DB97-477B-A612-BD6E6416E56BQ37521065-C812648E-28E6-42E3-868D-256C7268E260Q37703799-C7A87485-0D57-4F50-BA14-7FE27F5D9166Q38133441-B94F7F95-5E07-44D1-8250-A3B749002CFAQ41013852-78BEF51D-A44A-45DF-B9E3-E7302E7DBA9BQ42642413-ED9C2119-BE43-484E-AA25-AF59F95E0554Q46249781-DA42F6D7-6CBE-4051-99D2-C7063C082669Q46842600-F1EB480E-3AB2-4AE7-A4AB-4C7B3158C2F2Q48010788-1CFAD9B4-FB1D-4F36-B0AD-DB2135F36402Q48124701-56B2B1C0-52EC-4F7D-AA67-2D6D84495210Q48307841-80671DE9-67DC-4149-BD34-BE3AA0468658Q48389923-C4C92E11-865D-4F4F-B0C8-DD4A006C16BFQ48889010-D95C82E2-8A07-4571-A567-5EB7E55E8B9AQ51491526-DA042E07-373E-479F-AA07-CA7BF2DD5701Q52347263-9A0C4C39-775A-4647-B693-4536DEB94484Q58769659-834E1739-6B02-4D88-9A75-760329BA70B5
P2860
Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation.
description
1988 nî lūn-bûn
@nan
1988 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Nervous system involvement in ...... l and biochemical correlation.
@ast
Nervous system involvement in ...... l and biochemical correlation.
@en
Nervous system involvement in ...... l and biochemical correlation.
@nl
type
label
Nervous system involvement in ...... l and biochemical correlation.
@ast
Nervous system involvement in ...... l and biochemical correlation.
@en
Nervous system involvement in ...... l and biochemical correlation.
@nl
prefLabel
Nervous system involvement in ...... l and biochemical correlation.
@ast
Nervous system involvement in ...... l and biochemical correlation.
@en
Nervous system involvement in ...... l and biochemical correlation.
@nl
P2093
P2860
P356
P1433
P1476
Nervous system involvement in ...... l and biochemical correlation.
@en
P2093
P2860
P304
P356
10.1002/ANA.410230513
P577
1988-05-01T00:00:00Z